Cocoon Bioscience, founded in 2022 and headquartered in Spain, is an innovative player in the biotech industry dedicated to sustainability. The company operates under the slogan "Proteins For Sustainability" and focuses on the production of high-value enzymes. This is achieved through a novel approach that utilizes cocooned insects as natural, cost-effective bioreactors on an automated platform.
Recently, Cocoon Bioscience secured a €2.00M investment in a Venture Round dated 03 November 2023. This latest financial injection comes from a diverse group of investors, including Cleon Capital, Columbus Venture Partners, Viscofan, North South Ventures, Sangha Capital SA, Mondragon Health, Bexen Medical, and Spri.
The company’s unique biotechnological approach presents significant potential for lowering enzyme production costs and enhancing sustainability in various industrial applications, making it a promising candidate for further investment and partnership opportunities.